We asked some of our students what made them choose to study at NDO...

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving hea...

No one builds a scientific career alone.In this video researchers...

Infusoria 26 September – 6 November 2026Artlink Corridor Gallery, John Radcliffe Hospital, Oxford From hospital sinks to BioArt: our microbiology research inspires new exhibition Infusoria What does the microbial world of a hospital sink look like when viewed not only through the lens of microbiology, but through art? Research from Modernising Medical Microbiology (MMM) at the University of Oxford…

A brain imaging and stimulation study led by the University of Oxford has identified the brain mechanisms that help us work out whether the consequences we experience are caused by our own actions or by circumstances beyond our control.

Professor of Orthopaedic Trauma Matthew Costa and NIHR Doctoral Research Fellow Rachel Kuo, both from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, were announced among the winners of the NIHR20 Research Leaders Prizes in recognition of their outstanding contributions to health and care research.

How cells respond to the leukemia drug 6-thioguanine still holds surprises: A new study, led jointly by researchers from the Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM) and the University of Oxford identifies NUDT5 as an unexpected regulator of drug sensitivity and reveals that its role has nothing to do with its enzymatic activity.

The proportion of London children with clinically impaired lung function fell from around one in seven to one in 11 over five years following the introduction of London’s Ultra Low Emission Zone (ULEZ), according to a major five-year study jointly led by researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford.

Oxford researchers launch RobustiPy, a new open-source tool designed to ensure research is robust and reliable.